4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kingworld Medicines Group Limited (1110) operates in the Pharmaceutical Retailers industry and is headquartered in Shenzhen, China with about 732 employees. Its market capitalization is roughly CNY 275 million. In the fiscal year ended 2025-12-31, 1110 reported CNY 917M in revenue and CNY 11M in net income.
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 917M | CNY 1.1B | CNY 1.1B | CNY 958M | — |
| Gross Profit | CNY 248M | CNY 270M | CNY 281M | CNY 278M | — |
| Operating Income (EBIT) | CNY 51M | CNY 69M | CNY 63M | CNY 63M | — |
| Net Income | CNY 11M | CNY 42M | CNY 38M | CNY 23M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 18M) | (CNY 20M) | (CNY 14M) | (CNY 13M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.4B | CNY 1.4B | CNY 1.3B | CNY 1.3B | — |
| Total Liabilities | CNY 754M | CNY 710M | CNY 638M | CNY 569M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1110 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms